Pulmonary Embolism Notes

Pulmonary Embolism

Anatomy of the Lungs and Circulation

  • Refer to Slides CFB for details.

Role of Peripheral and Central Chemoreceptors

Peripheral Chemoreceptors
  • Located in the carotid (CN9) and aortic bodies (CN10).
  • Detect changes in:
    • Decrease in PO2PO_2
    • Increase in PCO2PCO_2
    • Decrease in blood pH
  • Upon detection, stimulate the inspiratory center (dorsal medullary center) to:
    • Increase ventilation
    • Increase gas exchange
Central Chemoreceptors
  • Located in the medulla oblongata.
  • Primarily detect an increase in PCO2PCO_2 and H+H^+.
  • H+H^+ cannot cross the blood-brain barrier directly.
  • When CO2CO_2 increases in the blood:
    • It diffuses across the blood-brain barrier.
    • Converts into H<em>2CO</em>3H<em>2CO</em>3, which hydrolyzes into H+H^+ and HCO3HCO_3^-.
  • Chemoreceptors detect H+H^+ and send signals to the inspiratory center to:
    • Increase ventilation
    • Decrease CO2CO_2 levels in the blood and CSF

Causes of Pulmonary Embolism (PE) and Mechanisms

Embolism: Transport of abnormal material via the bloodstream impacting blood vessels.

Risk Factors and Mechanisms
  • Pregnancy
    • Growing fetus compresses veins, slowing blood flow.
    • Increased attachment of platelets and clotting factors to vascular endothelial cells.
    • Activation of the coagulation cascade.
    • May also involve a naturally hypercoagulable state mediated by increased clotting factors and fibrinogen.
  • Inactivity in the Skeletal Muscle Pump
    • Slowed blood flow increases platelet and clotting factor attachment to blood vessels.
    • Activation of the coagulation cascade.
  • Surgery
    • Damage to vascular endothelial cells exposes tissue factor and collagen.
    • Activation of platelets and clotting factors, leading to platelet aggregation and coagulation cascade.
  • Inherited Antithrombin III Deficiency
    • Increased risk of clot formation.
    • Antithrombin III works by attaching to thrombin and clotting factors 7, 9, 10, 11, and 12.
  • Oral Contraceptives and Hormone Replacement Therapy
    • Increase clotting factor production.
    • Decrease Protein C and Antithrombin III levels, promoting clot formation.
  • Non-Main Causes
    • Fat embolism
    • Air embolism
    • Thrombus
    • Amniotic fluid embolism

Thrombosis

  • Formation of a solid mass from blood constituents while moving through the vascular system.
  • Related to Virchow's Triad
    • Stasis and Turbulent Flow:
      • Slow blood flow due to turbulence or skeletal muscle pump inactivity.
      • Platelets and clotting factors contact endothelium resulting in prolonged interaction leading to clotting factor adhesion and activation of clotting cascade.
    • Hypercoagulation:
      • Altered amount of clotting factors that increase primary or secondary hemostasis.
      • Can be due to genetics, surgery, or medications.
    • Damage to Endothelial Cell Lining: of a blood vessel.

Definition of Pulmonary Embolism

  • Blockage of an artery in the pulmonary circulation by blood clots or thrombus.
    • 95% of PE cases are secondary to Deep Vein Thrombosis (DVT).
    • DVT involves thrombus formation in the legs or pelvis.
      • Fragmented emboli travel through the veins to the inferior vena cava and then to the pulmonary arteries.
  • Emboli Location:
    • Occluding: in the main pulmonary artery
    • Straddle (Saddle): at the pulmonary artery bifurcation
    • Obstructing: in pulmonary arterioles
  • Obstruction can be partial or complete.

Hemodynamic Changes Following PE

Impact on Pressure
  • Increased right ventricular afterload.
    • Increased right ventricular pressure.
      • Increased right atrial pressure.
        • Increased central venous pressure.
Impact on Volume
  • Pulmonary hypertension.
    • Increased right ventricular volume.
      • Increased stretch and dilation.
        • Stretch of the tricuspid valve.
          • Regurgitation during systole.
            • Increased right atrial blood volume and jugular venous pressure (JVP).
Impact on Blood Flow
  • Obstruction of blood flow.
    • Decreased blood return to the left side of the heart.
      • Decreased end-diastolic volume (EDV).
        • Decreased stroke volume (SV) and cardiac output.
          • Decreased blood pressure (BP).

Clinical Features of PE

  • Depend on the size of the embolus.
    • Small Embolus
      • Impacts distal/terminal arteries and arterioles.
      • Unlikely to cause significant signs or symptoms.
    • Large Embolus
      • Major arterial obstruction.
        • Acute pulmonary hypertension.
          • Right-sided heart failure.
      • If the embolus breaks up (due to blood force) and impacts terminal arteries near the pleural membrane, it can cause:
        • Pleural effusion and pleuritic chest pain.
Clinical Manifestations
  • Collapse
  • Pleuritic chest pain
  • Acute breathlessness
  • Pleural effusion
  • Raised JVP
  • Heave and crackles on auscultation
  • Low BP
  • Pulmonary hypertension
  • Right ventricular failure
  • Coughing blood

Changes in Arterial Blood Gases

  • Low Oxygen
    • Due to obstruction by the clot.
    • Ventilation-perfusion mismatch.
  • Low Oxygen
    • Due to pulmonary edema and fluid around alveoli, compromising gas exchange.
    • Ventilation-perfusion mismatch.
  • Changes in CO2CO_2 Levels
    • Initially, hypercapnia (increased CO2CO_2).
    • Becomes hypocapnia (decreased CO2CO_2) due to chemoreceptor activation, which increases ventilation.
  • Low Sats (Low Blood O2O_2)

Pathogenesis of Pulmonary Edema

Exudate
  • Divided into intravascular and extravascular components.
    • Intravascular
      • Embolus impact causes vascular endothelial injury.
        • Leads to inflammation.
          • Increased cytokines.
            • Increased vascular permeability.
              • Inflammatory cells and mediators leak out of blood vessels into the tissue, causing edema.
    • Extravascular
      • Embolus impact obstructs blood flow.
        • Ischemia of tissues and bronchioles distal to the obstruction.
          • Inflammation of lung tissues and bronchioles.
            • Increased cytokine production and recruitment of other inflammatory cells, leading to edema.
Transudate
  • Embolus impact.
    • Obstruction of blood flow causes pulmonary hypertension.
      • Increased hydrostatic pressure in capillaries behind the obstruction.
        • Leakage of plasma into lung tissue, resulting in edema.
      • If pressure is excessively high, capillaries may rupture.
        • Leaking blood into the tissues, causing edema.